Anti-tumor necrosis factor α F(ab')2 antibody fragments protect in murine polymicrobial sepsis: Concentration and early intervention are fundamental to the outcome (original ) (raw )The role of tumor necrosis factor in sepsis
Louis Saravolatz
Clinical immunology and immunopathology, 1992
View PDFchevron_right
Dosage and Timing of Anti-TNF-α Antibody Treatment Determine Its Effect on Resistance to Sepsis after Injury
Richard Molloy
Journal of Surgical Research, 1996
View PDFchevron_right
LYMPHOTOXIN-α (TNF-β) DURING SEPSIS
david moyes
Cytokine, 1996
View PDFchevron_right
SERUM PROFILE OF IL6, TNFALPHA, IL12 AND IFNGAMMA IN EARLY SEPSIS
Adriana Slavcovici
View PDFchevron_right
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
Didier Ledoux
Annals of Surgery, 1992
View PDFchevron_right
Acute Lung Injury and Acute Kidney Injury Are Established by Four Hours in Experimental Sepsis and Are Improved with Pre, but Not Post, Sepsis Administration of TNF-α Antibodies
A. Andres-hernando , Christopher Altmann
PLoS ONE, 2013
View PDFchevron_right
Anti-TNF Treatment of Baboons with Sepsis Reduces TNF-α, IL-6 and IL-8, but not the Degree of Complement Activation
Heinz Redl
Scandinavian Journal of Immunology, 1998
View PDFchevron_right
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
Steven Berman , Richard Wunderink
Journal of Cardiothoracic and Vascular Anesthesia, 1998
View PDFchevron_right
Pathophysiological role of pro-and anti-inflammatory cytokines in sepsis
Jean Marc Cavaillon
Sepsis, 1998
View PDFchevron_right
Is TNF-α a prognostic factor in patients with sepsis?
Pramod Shah
Clinical Microbiology and Infection, 1997
View PDFchevron_right
Immunopathologic alterations in murine models of sepsis of increasing severity
Samuel Ebong
Infection and immunity, 1999
View PDFchevron_right
Inhibition of Macrophage-activating Cytokines is Beneficial in the Acute Septic Response
Henry Redmond
Annals of Surgery, 1991
View PDFchevron_right
Vascular Endothelial Growth Factor Blockade Reduces Plasma Cytokines in a Murine Model of Polymicrobial Sepsis
Anna Nolan
Inflammation, 2004
View PDFchevron_right
Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis
Richard Knight , Catherine Betts
Inflammation Research, 2014
View PDFchevron_right
Are alterations of lymphocyte subpopulations in polymicrobial sepsis and DHEA treatment mediated by the tumour necrosis factor (TNF)-αreceptor (TNF-RI)? A study in TNF-RI (TNF-RI–/–) knock-out rodents
Christian Krettek
Clinical and Experimental Immunology, 2004
View PDFchevron_right
Immunopathologic responses to non-lethal sepsis
Samuel Ebong
1999
View PDFchevron_right
Immunoinflammatory Response in Critically Ill Patients: Severe Sepsis and/or Trauma
Jasna Jevdjic , Milic Veljovic
Mediators of Inflammation, 2013
View PDFchevron_right
Is TNF-a a prognostic factor in patients with sepsis?
Pramod Shah
Clin Microbiol Infect, 1997
View PDFchevron_right
Proinflammatory versus anti-inflammatory response in sepsis patients: looking at the cytokines
Sumit Ray
Critical Care, 2014
View PDFchevron_right
Immunomodulation in Polytrauma and Polymicrobial Sepsis - Where Do We Stand?
Claudia Neunaber
Recent Patents on Inflammation & Allergy Drug Discovery, 2011
View PDFchevron_right
Double-blind randomised controlled-trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock (NORASEPT II Study Group)
Guillermo Gutierrez
Lancet, 1998
View PDFchevron_right
Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review
Jean Marc Cavaillon
Journal of endotoxin research, 2001
View PDFchevron_right
Divergence of protection induced by bacterial products and sepsis-induced immune suppression. Infect. Immun
Theo Sterns
2005
View PDFchevron_right
Involvement of Pro- and Anti-Inflammatory Cytokines in Sepsis
Jenna Ziebell
The Sepsis Text, 2002
View PDFchevron_right
Potentia Hazards of Combination Immunotherapy in the Treatment of Experimental Septic Shock
Alan Cross
Journal of Infectious Diseases, 1996
View PDFchevron_right
Divergence of Protection Induced by Bacterial Products and Sepsis-Induced Immune Suppression
Theo Sterns
View PDFchevron_right